Monthly News Roundup - December 2019

FDA OKs Ubrelvy as First Oral Gepant for Migraine Treatment Migraine headache is a neurological disease with incapacitating symptoms that impacts 31 million Americans. In response, this month the FDA approved Ubrelvy (ubrogepant) from Allergan for...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news